DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent global survey of 101 biotech ...
ICON’s ICLR focus on Patient Access & Engagement strategy is a major tailwind along with partnerships and acquisitions. The stock carries a Zacks Rank #2 (Buy) currently. ICON is gaining from its ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation (CRO), finishes the second half of 2023 with positive recognition as a ...
There’s no question that the past few months have been incredibly volatile for both traditional equity and crypto markets. At the very end of Q2, Bitcoin saw record breaking volatility, experiencing ...
BERN, JUNE 2 — Building on 36 years of partnership and innovation in Switzerland, Microsoft today announced a USD 400 million investment to further strengthen both cloud and artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results